2023 Q4 Form 10-Q Financial Statement

#000165495423014022 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $6.742M $7.330M
YoY Change 13.79% -1.9%
Cost Of Revenue $2.291M $2.250M
YoY Change -1.29% -22.89%
Gross Profit $4.451M $5.090M
YoY Change 23.5% 11.77%
Gross Profit Margin 66.02% 69.44%
Selling, General & Admin $1.890M $1.297M
YoY Change 8.25% 6.31%
% of Gross Profit 42.46% 25.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.465M $2.930M
YoY Change -47.84% 26.68%
% of Gross Profit 55.38% 57.56%
Operating Expenses $4.354M $6.474M
YoY Change -32.73% 0.36%
Operating Profit $97.00K $856.0K
YoY Change -103.38% -16.16%
Interest Expense $150.0K $90.00K
YoY Change 94.81%
% of Operating Profit 154.64% 10.51%
Other Income/Expense, Net $0.00 $93.00K
YoY Change -100.0% 60.34%
Pretax Income -$4.021M $950.0K
YoY Change 44.43% -11.96%
Income Tax
% Of Pretax Income
Net Earnings -$4.021M $949.0K
YoY Change 44.43% -12.05%
Net Earnings / Revenue -59.64% 12.95%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share -$0.05 $0.01
COMMON SHARES
Basic Shares Outstanding 87.25M shares 87.04M shares
Diluted Shares Outstanding 87.11M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.52M $13.20M
YoY Change -37.09% -51.76%
Cash & Equivalents $20.72M $13.20M
Short-Term Investments
Other Short-Term Assets $260.0K $300.0K
YoY Change 4.42% -5.06%
Inventory
Prepaid Expenses
Receivables $5.790M $5.600M
Other Receivables $42.00K $0.00
Total Short-Term Assets $24.61M $19.16M
YoY Change -23.36% -36.9%
LONG-TERM ASSETS
Property, Plant & Equipment $91.91M $87.90M
YoY Change 14.57% 24.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.443M $3.803M
YoY Change -35.42% 2.18%
Total Long-Term Assets $95.45M $91.73M
YoY Change 13.63% 23.77%
TOTAL ASSETS
Total Short-Term Assets $24.61M $19.16M
Total Long-Term Assets $95.45M $91.73M
Total Assets $120.1M $110.9M
YoY Change 3.4% 6.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.580M $1.054M
YoY Change 322.88% 46.59%
Accrued Expenses $8.712M $2.354M
YoY Change -37.03% 29.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.90M $5.347M
YoY Change 11.42% 46.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.393M $3.200M
YoY Change -11.01% 53.85%
Total Long-Term Liabilities $2.393M $3.200M
YoY Change -11.01% 53.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.90M $5.347M
Total Long-Term Liabilities $2.393M $3.200M
Total Liabilities $21.29M $8.593M
YoY Change 8.35% 49.81%
SHAREHOLDERS EQUITY
Retained Earnings -$126.5M -$122.5M
YoY Change -0.21% -1.21%
Common Stock $87.00K $87.00K
YoY Change 1.16% 1.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $98.77M $102.3M
YoY Change
Total Liabilities & Shareholders Equity $120.1M $110.9M
YoY Change 3.4% 6.14%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$4.021M $949.0K
YoY Change 44.43% -12.05%
Depreciation, Depletion And Amortization $2.465M $2.930M
YoY Change -47.84% 26.68%
Cash From Operating Activities $12.05M $3.060M
YoY Change 303.45% -47.81%
INVESTING ACTIVITIES
Capital Expenditures $6.966M $2.690M
YoY Change 730.27% -296.93%
Acquisitions
YoY Change
Other Investing Activities -$1.127M $380.0K
YoY Change 7950.0%
Cash From Investing Activities -$8.083M -$2.320M
YoY Change 847.6% 69.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 12.05M 3.060M
Cash From Investing Activities -8.083M -2.320M
Cash From Financing Activities 0.000 0.000
Net Change In Cash 3.968M 740.0K
YoY Change 87.26% -83.54%
FREE CASH FLOW
Cash From Operating Activities $12.05M $3.060M
Capital Expenditures $6.966M $2.690M
Free Cash Flow $5.085M $370.0K
YoY Change 136.73% -94.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
81606000 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
79372000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
337000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3803000 usd
CY2023Q3 us-gaap Assets
Assets
110883000 usd
us-gaap Lease Cost
LeaseCost
7540000 usd
us-gaap Lease Cost
LeaseCost
8076000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1546000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24042000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
24109000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
dei Entity Central Index Key
EntityCentralIndexKey
0001141197
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87250267 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85790267 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35922
dei Entity Registrant Name
EntityRegistrantName
PEDEVCO Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-3755993
dei Entity Address Address Line1
EntityAddressAddressLine1
575 N. Dairy Ashford
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77079
dei City Area Code
CityAreaCode
713
dei Local Phone Number
LocalPhoneNumber
221-1768
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
PED
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
87250267 shares
CY2023Q3 us-gaap Cash
Cash
13200000 usd
CY2022Q4 us-gaap Cash
Cash
29430000 usd
CY2023Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
5615000 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
2430000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
342000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
249000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
19157000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
32109000 usd
CY2023Q3 us-gaap Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost
OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost
5980000 usd
CY2022Q4 us-gaap Oil And Gas Producing Properties Of Rate Regulated Companies Unamortized Cost
OilAndGasProducingPropertiesOfRateRegulatedCompaniesUnamortizedCost
775000 usd
CY2023Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
87586000 usd
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
80147000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3783000 usd
CY2022Q4 us-gaap Assets
Assets
116110000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1054000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1556000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2354000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13835000 usd
CY2023Q3 ped Revenue Payable Current
RevenuePayableCurrent
956000 usd
CY2022Q4 ped Revenue Payable Current
RevenuePayableCurrent
1018000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
87000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81000 usd
CY2023Q3 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
896000 usd
CY2022Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
472000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5347000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16962000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2996000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2689000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
8593000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
19651000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87250267 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85790267 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
87000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
86000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
224659000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
223114000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122456000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126741000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
102290000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
96459000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110883000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
116110000 usd
CY2023Q3 us-gaap Revenues
Revenues
7330000 usd
CY2022Q3 us-gaap Revenues
Revenues
7472000 usd
us-gaap Revenues
Revenues
24042000 usd
us-gaap Revenues
Revenues
24109000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
2245000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
2918000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1297000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1220000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8411000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6427000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
6474000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
6451000 usd
us-gaap Operating Expenses
OperatingExpenses
20069000 usd
us-gaap Operating Expenses
OperatingExpenses
18611000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
856000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1021000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3973000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5498000 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
88000 usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
33000 usd
us-gaap Interest Income Other
InterestIncomeOther
272000 usd
us-gaap Interest Income Other
InterestIncomeOther
40000 usd
CY2023Q3 us-gaap Other Income
OtherIncome
5000 usd
CY2022Q3 us-gaap Other Income
OtherIncome
25000 usd
us-gaap Other Income
OtherIncome
40000 usd
us-gaap Other Income
OtherIncome
90000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
93000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
312000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
949000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1079000 usd
us-gaap Net Income Loss
NetIncomeLoss
4285000 usd
us-gaap Net Income Loss
NetIncomeLoss
5628000 usd
CY2023Q3 ped Basic Earnings Per Share
BasicEarningsPerShare
0.01
CY2022Q3 ped Basic Earnings Per Share
BasicEarningsPerShare
0.01
ped Basic Earnings Per Share
BasicEarningsPerShare
0.05
ped Basic Earnings Per Share
BasicEarningsPerShare
0.07
CY2023Q3 ped Diluted Earnings Per Share
DilutedEarningsPerShare
0.01
CY2022Q3 ped Diluted Earnings Per Share
DilutedEarningsPerShare
0.01
ped Diluted Earnings Per Share
DilutedEarningsPerShare
0.05
ped Diluted Earnings Per Share
DilutedEarningsPerShare
0.07
CY2023Q3 ped Basic Weighted Average Number Of Shares Outstanding
BasicWeightedAverageNumberOfSharesOutstanding
87108745 shares
CY2022Q3 ped Basic Weighted Average Number Of Shares Outstanding
BasicWeightedAverageNumberOfSharesOutstanding
85644180 shares
ped Basic Weighted Average Number Of Shares Outstanding
BasicWeightedAverageNumberOfSharesOutstanding
86958033 shares
ped Basic Weighted Average Number Of Shares Outstanding
BasicWeightedAverageNumberOfSharesOutstanding
85419689 shares
CY2023Q3 ped Diluted Weighted Average Number Of Shares Outstanding
DilutedWeightedAverageNumberOfSharesOutstanding
87108745 shares
CY2022Q3 ped Diluted Weighted Average Number Of Shares Outstanding
DilutedWeightedAverageNumberOfSharesOutstanding
85644180 shares
ped Diluted Weighted Average Number Of Shares Outstanding
DilutedWeightedAverageNumberOfSharesOutstanding
86958033 shares
ped Diluted Weighted Average Number Of Shares Outstanding
DilutedWeightedAverageNumberOfSharesOutstanding
85419689 shares
us-gaap Net Income Loss
NetIncomeLoss
4285000 usd
us-gaap Net Income Loss
NetIncomeLoss
5628000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8411000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6427000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
86000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
75000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1572000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3185000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-899000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-93000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
10000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-232000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-243000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
669000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
366000 usd
ped Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
-62000 usd
ped Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
58000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11425000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12994000 usd
ped Drilling And Completion Costs Payment
DrillingAndCompletionCostsPayment
-27985000 usd
ped Drilling And Completion Costs Payment
DrillingAndCompletionCostsPayment
-11413000 usd
us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
366000 usd
us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
0 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
9000 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 usd
ped Payment For Cash Paid For Vehicle
PaymentForCashPaidForVehicle
45000 usd
ped Payment For Cash Paid For Vehicle
PaymentForCashPaidForVehicle
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27655000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11413000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-16230000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1631000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32977000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29227000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16747000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30858000 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
ped Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
12558000 usd
ped Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
1791000 usd
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
131000 usd
us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
158000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
96459000 usd
CY2023Q1 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
518000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1762000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
98739000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
517000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1574000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
100830000 usd
CY2023Q3 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
511000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
102290000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
91483000 usd
CY2022Q1 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
563000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1339000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
93385000 usd
CY2022Q2 ped Sale Of Common Stock To Non Affiliate Amount
SaleOfCommonStockToNonAffiliateAmount
50000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
537000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3210000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
97182000 usd
CY2022Q3 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
472000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1079000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
98733000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7330000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7472000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13200000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29430000 usd
CY2023Q3 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
3547000 usd
CY2022Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
3547000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
16747000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
32977000 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
176253000 usd
CY2023Q3 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
186108000 usd
CY2022Q4 ped Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
775000 usd
CY2023Q3 ped Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
5981000 usd
CY2022Q4 ped Asset Retirement Costs
AssetRetirementCosts
1407000 usd
CY2023Q3 ped Asset Retirement Costs
AssetRetirementCosts
1538000 usd
CY2022Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
98288000 usd
CY2023Q3 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
106041000 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
80147000 usd
CY2023Q3 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
87586000 usd
us-gaap Cost Depletion
CostDepletion
9985000 usd
ped Description Of Additional Acquired
DescriptionOfAdditionalAcquired
The Company also acquired approximately 282 net mineral acres, and 6,305 net lease acres
CY2023Q3 ped Cost Of Due Deligence
CostOfDueDeligence
493000 usd
CY2022Q4 ped Cost Of Due Deligence
CostOfDueDeligence
4946000 usd
CY2023Q3 us-gaap Development Costs
DevelopmentCosts
16000 usd
CY2023Q3 ped Proceeds From Net
ProceedsFromNet
366000 usd
CY2023Q3 ped Description Of Additional Acquired
DescriptionOfAdditionalAcquired
Evolution acquired a 50% working interest share in existing leases, covering the initial two Development Blocks (which equals Evolution’s share of the acreage portion for nine drilling locations therein), and upon completion of the wells in each Development Block, Evolution will have the right, but not the obligation, to acquire a 50% working interest
CY2023Q3 us-gaap Subordinated Borrowing Interest Rate
SubordinatedBorrowingInterestRate
0.50 pure
CY2023Q3 us-gaap Depletion
Depletion
2616000 usd
CY2022Q3 us-gaap Depletion
Depletion
2084000 usd
us-gaap Depletion
Depletion
7753000 usd
us-gaap Depletion
Depletion
5956000 usd
ped Asset Retirement Obligations
AssetRetirementObligations
3161000 usd
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
642000 usd
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
42000 usd
ped Changes In Estimates Net Value
ChangesInEstimatesNetValue
131000 usd
ped Asset Retirement Obligations Ending
AssetRetirementObligationsEnding
3892000 usd
CY2022Q4 ped Settlement Cureent Asset Retirement
SettlementCureentAssetRetirement
472000 usd
CY2023Q3 ped Settlement Cureent Asset Retirement
SettlementCureentAssetRetirement
896000 usd
ped Office Space
OfficeSpace
5200 sqft
ped Office Spaceleaseexpirationdate
OfficeSpaceleaseexpirationdate
2023-08-31
us-gaap Other Expenses
OtherExpenses
10000 usd
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-02-28
ped Lease Payments Description
LeasePaymentsDescription
The base monthly rent will be approximately $9,200 for the first 18 months and increase to approximately $9,500 thereafter. The Company paid both a security deposit and prepaid rent for $14,700, respectively
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
77000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
337000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
87000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
250000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
337000 usd
ped Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P3Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0790 pure
ped Supplemental Information Related To Operating Leasetabletextblock
SupplementalInformationRelatedToOperatingLeasetabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Remainder of 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">28</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">110</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">112</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">2026</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">115</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Thereafter</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">19</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total lease payments</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">384</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less imputed interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(47</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">337</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
28000 usd
CY2023Q3 ped Lessee Operating Lease Liability Payments Due Next One Months
LesseeOperatingLeaseLiabilityPaymentsDueNextOneMonths
110000 usd
CY2023Q3 ped Lessee Operating Lease Liability Payments Due Next Two Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwoMonths
112000 usd
CY2023Q3 ped Lessee Operating Lease Liability Payments Due Next Three Months
LesseeOperatingLeaseLiabilityPaymentsDueNextThreeMonths
115000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
19000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
384000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
47000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
337000 usd
us-gaap Other Commitments Description
OtherCommitmentsDescription
In the Permian Basin Asset, 32 acres are due to expire during the remainder of 2023 and 40 net acres expire thereafter (net to our direct ownership interest only)
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1460000 shares
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1229000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
1211000 usd
CY2023Q3 ped Intrinsic Value Of Outstanding And Exercisable
IntrinsicValueOfOutstandingAndExercisable
0 usd
ped Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Numbers
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumbers
1407667000 shares
ped Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price Ending
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceEnding
1.51
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
540000000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
241666000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.14
ped Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber
1706001000 shares
ped Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice
1.29
ped Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a
P3Y
ped Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Numbers
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumbers
739334000 shares
ped Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Prices
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrices
1.46
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y10M24D
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
949000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1079000 usd
us-gaap Net Income Loss
NetIncomeLoss
4285000 usd
us-gaap Net Income Loss
NetIncomeLoss
5628000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87108745 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85644180 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86958033 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85419689 shares
CY2023Q3 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2022Q3 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Dilutive Securities
DilutiveSecurities
0 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87108745 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85644180 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86958033 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85419689 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q3 ped Share Equivalents Related To Options To Purchase Of Commmon Stock
ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock
1706001 shares
ped Share Equivalents Related To Options To Purchase Of Commmon Stock
ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock
1456000 shares
CY2022Q3 ped Share Equivalents Related To Options To Purchase Of Commmon Stock
ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock
1706001 shares
ped Share Equivalents Related To Options To Purchase Of Commmon Stock
ShareEquivalentsRelatedToOptionsToPurchaseOfCommmonStock
1456000 shares

Files In Submission

Name View Source Status
0001654954-23-014022-index-headers.html Edgar Link pending
0001654954-23-014022-index.html Edgar Link pending
0001654954-23-014022.txt Edgar Link pending
0001654954-23-014022-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ped-20230930.xsd Edgar Link pending
ped_10q.htm Edgar Link pending
ped_10qimg2.jpg Edgar Link pending
ped_ex102.htm Edgar Link pending
ped_ex311.htm Edgar Link pending
ped_ex312.htm Edgar Link pending
ped_ex321.htm Edgar Link pending
ped_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ped-20230930_cal.xml Edgar Link unprocessable
ped-20230930_def.xml Edgar Link unprocessable
ped-20230930_lab.xml Edgar Link unprocessable
ped-20230930_pre.xml Edgar Link unprocessable
ped_10q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending